HOME >> MEDICINE >> NEWS
Accountability in Clinical Research: Balancing Risk and Benefit

INDIANAPOLIS - Human participation in research has surged in recent years as scientists seek causes and cures of myriad diseases. Accompanying the increase too has been greater public concern for patient safety and scrutiny of complex ethical, legal and regulatory issues.

Such issues will be tackled April 24-26 by Indiana University School of Medicine physicians and researchers and other prominent scientists at a national forum at the University Place Conference Center on the Indiana University-Purdue University Indianapolis campus. Accountability in Clinical Research: Balancing Risk and Benefit, sponsored by the National Patient Safety Foundation, will examine the management, conduct, funding and accountability of research involving human subjects.

Sharon M. Moe, M.D., IU School of Medicine's assistant dean for research support, will lead talks in a session about the role of oversight in assuring patient safety in clinical research. Eric M. Meslin, Ph.D., director of the IU Center for Bioethics, takes the lead in discussing the quality and content of information supplied to research patients about their roles and risks Media interest in biomedical research also has sharply increased, often focusing on controversial incidents involving health outcomes of patients. David W. Crabb, M.D., chairman of the School's Department of Medicine, and members of Indianapolis' news media will discuss and analyze real and hypothetical situations and responses to media coverage.

"This conference opens the door to continued dialogue about patient safety issues in clinical research settings," says Carol A. Ley, M.D., Ph.D., chair of NPSF's board of directors.

"The insight and experiences shared at this conference will be invaluable to health-care professionals, researchers, consumers and government entities - all essential in moving patient safety messages to a new level."

Today's health care consumers, payers, providers and profess
'"/>

Contact: Joe Stuteville
jstutevi@iupui.edu
317-274-7722
Indiana University
10-Apr-2002


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Accountability Clinical Research Balancing Risk and Benefit

(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... virus that causes common cold sores -- herpes simplex -- ... Swedish researchers suggest. In fact, being a carrier of ... Alzheimer,s disease, the researchers found. "The identification of ... disorder is a breakthrough," said lead researcher Dr. Hugo Lovheim, ...
(Date:10/25/2014)... (HealthDay News) -- Researchers who discovered antibiotics in ... cause for concern. The use of antibiotics ... human consumption contribute to the development of antibiotic-resistant ... information from the study. Each year in ... million people and kill about 23,000, according to ...
(Date:10/25/2014)... (HealthDay News) -- Current osteoporosis screening guidelines and ... at risk for osteoporosis-related fractures, a new study ... we need tools that help us accurately predict ... we can target these at-risk people for preventive ... medicine in the division of general internal medicine ...
(Date:10/25/2014)... 24, 2014 (HealthDay News) -- October,s shorter, darker days ... affective disorder, according to an expert. People ... feel overly tired, lack motivation and even have trouble ... lead to suicide, said Dr. Angelos Halaris, a professor ... Loyola University Chicago Stitch School of Medicine. "Seasonal ...
(Date:10/22/2014)... 22, 2014 On Saturday, October 25, 2014, ... annual family health and fitness fair ¡Vive tu vida! Get ... and good nutrition for better health and wellness for people ... free and open to the public, will be held at ... 9:00 am to 1:00 pm. , “¡Vive tu Vida! ...
Breaking Medicine News(10 mins):Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
(Date:10/25/2014)... -- Burzynski Research Institute, Inc. (BRI) announced today that ... the company permission to conduct an open-label study of ... of age with a diffuse intrinsic brainstem glioma (DIPG). ... treatment groups based on their age and whether or ... primary study endpoint is a decrease in the size ...
(Date:10/22/2014)... 2014  Cephasonics, a technology-innovation leader with a game-changing ... (cQuest Ultrasound Box™-1), the first product in a new ... by Cephasonics for purchase by companies to rebrand with ... be showcasing the cQUB-1 for the first time at ... Chongqing, China from October 23 to ...
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
Breaking Medicine Technology:Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2
Cached News: